We are live on
!
Find out more
CA
Centerpoint Advisors Portfolio holdings
AUM
$307M
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.82%
1 Year Est. Return
+19.69%
3 Year Est. Return
+61.2%
5 Year Est. Return
+68.15%
10 Year Est. Return
–
AUM
$288M
AUM Growth
+$10.1M
(+3.6%)
Cap. Flow
-$4.9M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
66.82%
Holding
500
New
47
Increased
57
Reduced
79
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$659K |
| 2 |
Apple
AAPL
|
+$210K |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$141K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$113K |
| 5 |
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
|
+$42.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.11M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$743K |
| 3 |
NVIDIA
NVDA
|
+$679K |
| 4 |
Johnson & Johnson
JNJ
|
+$520K |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$266K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.12% |
| 2 | Communication Services | 4.2% |
| 3 | Healthcare | 3.74% |
| 4 | Financials | 2.72% |
| 5 | Consumer Discretionary | 1.79% |
Similar funds
TFA
ITB
HKIM
ICP
PC
AC
EWM
BBWA
Centerpoint Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Centerpoint Advisors held 500 positions worth $288M, up 3.6% from $278M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Centerpoint Advisors's Q3 2024 filing shows 47 new, 57 increased, 79 reduced and 18 closed positions. Its largest new stake was Syros Pharmaceuticals, Inc. Common Stock: 10,659 shares worth $23K. The largest sale was Eli Lilly, an estimated $1.11M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Communication Services and Healthcare.
- Centerpoint Advisors's largest Q3 2024 buy was Syros Pharmaceuticals, Inc. Common Stock: 10,659 shares worth $23K.
- Centerpoint Advisors added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $659K increase.
- Centerpoint Advisors's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.11M.
- Centerpoint Advisors fully exited Coca-Cola Femsa in Q3 2024, selling an estimated $96K.
- Centerpoint Advisors's ten largest holdings make up 67% of its $288M portfolio in Q3 2024.
- Centerpoint Advisors opened 47 new positions and closed 18 in Q3 2024.
- Centerpoint Advisors's portfolio value rose 3.6% quarter-over-quarter to $288M.
Based on Centerpoint Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.